Ernexa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ERNA and other ETFs, options, and stocks.About ERNA
Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications.
CEOSanjeev Luther
CEOSanjeev Luther
Employees6
Employees6
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1984
Founded1984
Employees6
Employees6
ERNA Key Statistics
Market cap8.26M
Market cap8.26M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$0.33
High today$0.33
Low today$0.2944
Low today$0.2944
Open price$0.3002
Open price$0.3002
Volume594.12K
Volume594.12K
52 Week high$4.50
52 Week high$4.50
52 Week low$0.2682
52 Week low$0.2682
Stock Snapshot
Ernexa Therapeutics(ERNA) stock is priced at $0.30, giving the company a market capitalization of 8.26M. It carries a P/E multiple of -0.06.
On 2026-03-05, Ernexa Therapeutics(ERNA) stock moved within a range of $0.29 to $0.33. With shares now at $0.30, the stock is trading +0.8% above its intraday low and -10.1% below the session's peak.
Trading volume for Ernexa Therapeutics(ERNA) stock has reached 594.12K, versus its average volume of 1.21M.
Over the past 52 weeks, Ernexa Therapeutics(ERNA) stock has traded between a high of $4.50 and a low of $0.27.
Over the past 52 weeks, Ernexa Therapeutics(ERNA) stock has traded between a high of $4.50 and a low of $0.27.
People also own
Based on the portfolios of people who own ERNA. This list is generated using Robinhood data, and it’s not a recommendation.